12-03-2025 | Drug-Induced Liver Injury | Original Research Article
The Frequency of Drug-Induced Liver Injury Due to Antibiotics Among Hospitalised Patients
Published in: Drug Safety
Login to get accessPlease log in to get access to this content
Appendix
Available only for authorised users
Literature
1.
go back to reference Björnsson E, Olsson R. Outcome and prognostic markers in severe drug-induced liver disease. Hepatology. 2005;42:481–9.CrossRefPubMed
Björnsson E, Olsson R. Outcome and prognostic markers in severe drug-induced liver disease. Hepatology. 2005;42:481–9.CrossRefPubMed
2.
go back to reference Chalasani N, Bonkovsky HL, Fontana R, Lee W, Stolz A, Talwalkar J, et al. Features and outcomes of 899 patients with drug-induced liver injury: the DILIN prospective study. Gastroenterology. 2015;148:1340-52.e7.CrossRefPubMed
Chalasani N, Bonkovsky HL, Fontana R, Lee W, Stolz A, Talwalkar J, et al. Features and outcomes of 899 patients with drug-induced liver injury: the DILIN prospective study. Gastroenterology. 2015;148:1340-52.e7.CrossRefPubMed
3.
go back to reference Stephens C, Robles-Diaz M, Medina-Caliz I, Garcia-Cortes M, Ortega-Alonso A, Sanabria-Cabrera J, et al. Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry. J Hepatol. 2021;75:86–97.CrossRefPubMed
Stephens C, Robles-Diaz M, Medina-Caliz I, Garcia-Cortes M, Ortega-Alonso A, Sanabria-Cabrera J, et al. Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry. J Hepatol. 2021;75:86–97.CrossRefPubMed
4.
go back to reference Björnsson ES, Bergmann OM, Björnsson HK, Kvaran R, Olafsson S. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology. 2013;144:1419–25.CrossRefPubMed
Björnsson ES, Bergmann OM, Björnsson HK, Kvaran R, Olafsson S. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology. 2013;144:1419–25.CrossRefPubMed
5.
go back to reference Bessone F, Hernandez N, Mendizabal M, Sanchez A, Paraná R, Arrese M, et al. When the creation of a consortium provides useful answers: experience of the Latin American DILI network (LATINDILIN). Clin Liver Dis (Hoboken). 2019;13:51–7.CrossRefPubMed
Bessone F, Hernandez N, Mendizabal M, Sanchez A, Paraná R, Arrese M, et al. When the creation of a consortium provides useful answers: experience of the Latin American DILI network (LATINDILIN). Clin Liver Dis (Hoboken). 2019;13:51–7.CrossRefPubMed
6.
go back to reference Devarbhavi H, Joseph T, Sunil Kumar N, Rathi C, Thomas V, Singh SP, et al. The indian network of drug-induced liver injury: etiology, clinical features, outcome and prognostic markers in 1288 patients. J Clin Exp Hepatol. 2021;11:288–98.CrossRefPubMed
Devarbhavi H, Joseph T, Sunil Kumar N, Rathi C, Thomas V, Singh SP, et al. The indian network of drug-induced liver injury: etiology, clinical features, outcome and prognostic markers in 1288 patients. J Clin Exp Hepatol. 2021;11:288–98.CrossRefPubMed
7.
go back to reference Björnsson ES, Stephens C, Atallah E, Robles-Diaz M, Alvarez-Alvarez I, Gerbes A, et al. A new framework for advancing in drug-induced liver injury research. The Prospective European DILI Registry. Liver Int. 2023;43:115–26.CrossRefPubMed
Björnsson ES, Stephens C, Atallah E, Robles-Diaz M, Alvarez-Alvarez I, Gerbes A, et al. A new framework for advancing in drug-induced liver injury research. The Prospective European DILI Registry. Liver Int. 2023;43:115–26.CrossRefPubMed
8.
go back to reference Björnsson B, Bergqvist A, Jerlstad P, Olsson R. Fulminant drug-induced hepatic failure leading to death or liver transplantation in Sweden. Scand J Gastroenterol. 2005;40:1095–101.CrossRefPubMed
Björnsson B, Bergqvist A, Jerlstad P, Olsson R. Fulminant drug-induced hepatic failure leading to death or liver transplantation in Sweden. Scand J Gastroenterol. 2005;40:1095–101.CrossRefPubMed
9.
go back to reference Reuben A, Koch DG, Lee WM. Drug-induced acute liver failure: results of a U.S. multicenter, prospective study. Hepatology. 2010;52:2065–76.CrossRefPubMed
Reuben A, Koch DG, Lee WM. Drug-induced acute liver failure: results of a U.S. multicenter, prospective study. Hepatology. 2010;52:2065–76.CrossRefPubMed
10.
go back to reference Wei G, Bergquist A, Broome U, Lindgren S, Wallerstedt S, Almer S, Sangfeldt P, et al. Acute liver failure in Sweden: etiology and outcome. J Intern Med. 2007;262:392–401.CrossRef
Wei G, Bergquist A, Broome U, Lindgren S, Wallerstedt S, Almer S, Sangfeldt P, et al. Acute liver failure in Sweden: etiology and outcome. J Intern Med. 2007;262:392–401.CrossRef
11.
go back to reference Björnsson ES, Hoofnagle JH. Categorization of drugs implicated in causing liver injury: critical assessment based upon published case reports. Hepatology. 2016;63:590–603.CrossRefPubMed
Björnsson ES, Hoofnagle JH. Categorization of drugs implicated in causing liver injury: critical assessment based upon published case reports. Hepatology. 2016;63:590–603.CrossRefPubMed
12.
go back to reference de Abajo FJ, Montero D, Madurga M, Garcia Rodrigues LA. Acute and clinically relevant drug-induced liver injury: a population based case-control study. Br J Clin Pharmacol. 2004;58:71–80.CrossRefPubMedPubMedCentral
de Abajo FJ, Montero D, Madurga M, Garcia Rodrigues LA. Acute and clinically relevant drug-induced liver injury: a population based case-control study. Br J Clin Pharmacol. 2004;58:71–80.CrossRefPubMedPubMedCentral
13.
go back to reference Suzuki A, Tillmann H, Williams J, Hauser RG, Frund J, Suzuki M, et al. Assessment of the frequency, phenotypes, and outcomes of acute liver injury associated with amoxicillin/clavulanate in 1.4 million patients in the Veterans Health Administration. Drug Saf. 2023;46:129–43.CrossRefPubMed
Suzuki A, Tillmann H, Williams J, Hauser RG, Frund J, Suzuki M, et al. Assessment of the frequency, phenotypes, and outcomes of acute liver injury associated with amoxicillin/clavulanate in 1.4 million patients in the Veterans Health Administration. Drug Saf. 2023;46:129–43.CrossRefPubMed
14.
go back to reference Kang Y, Kim S-H, Park SY, Park BY, Lee JH, An J, et al. Evaluation of drug-induced liver injury developed during hospitalization using electronic health record (HER)-based algorithm. Allergy Asthma Immunol Res. 2020;12:430–42.CrossRefPubMedPubMedCentral
Kang Y, Kim S-H, Park SY, Park BY, Lee JH, An J, et al. Evaluation of drug-induced liver injury developed during hospitalization using electronic health record (HER)-based algorithm. Allergy Asthma Immunol Res. 2020;12:430–42.CrossRefPubMedPubMedCentral
15.
16.
go back to reference Alqahtani SA, Kleiner DE, Ghabril M, Gu J, Hoofnagle JH, Rockey DC. Identification and characterization of cefazolin-induced liver injury. Dig Dis Sci. 2016;61:2406–16.
Alqahtani SA, Kleiner DE, Ghabril M, Gu J, Hoofnagle JH, Rockey DC. Identification and characterization of cefazolin-induced liver injury. Dig Dis Sci. 2016;61:2406–16.
17.
go back to reference Aithal GP, Watkins PB, Andrade RJ, Larrey D, Molokhia M, Takikawa H, et al. Case definition and phenotype standardization in drug-induced liver injury. Clin Pharmacol Ther. 2011;89:806–15.CrossRefPubMed
Aithal GP, Watkins PB, Andrade RJ, Larrey D, Molokhia M, Takikawa H, et al. Case definition and phenotype standardization in drug-induced liver injury. Clin Pharmacol Ther. 2011;89:806–15.CrossRefPubMed
18.
go back to reference Hayashi PH, Lucena MI, Fontana RJ, Bjornsson ES, Aithal GP, Barnhart H, et al. A revised electronic version of RUCAM for the diagnosis of drug induced liver injury. Hepatology. 2022;76:18–31.CrossRefPubMed
Hayashi PH, Lucena MI, Fontana RJ, Bjornsson ES, Aithal GP, Barnhart H, et al. A revised electronic version of RUCAM for the diagnosis of drug induced liver injury. Hepatology. 2022;76:18–31.CrossRefPubMed
19.
go back to reference De Valle MB, Av Klinteberg V, Alem N, Olsson R, Björnsson E. Drug-induced liver injury in a Swedish University hospital out-patient hepatology clinic. Aliment Pharmacol Ther. 2006;24:1187–95.CrossRefPubMed
De Valle MB, Av Klinteberg V, Alem N, Olsson R, Björnsson E. Drug-induced liver injury in a Swedish University hospital out-patient hepatology clinic. Aliment Pharmacol Ther. 2006;24:1187–95.CrossRefPubMed
20.
go back to reference Sgro C, Clinard F, Ouazir K, Chanay H, Allard C, Guilleminet C, et al. Incidence of drug-induced hepatic injuries: a French population-based study. Hepatology. 2002;36:451–5.CrossRefPubMed
Sgro C, Clinard F, Ouazir K, Chanay H, Allard C, Guilleminet C, et al. Incidence of drug-induced hepatic injuries: a French population-based study. Hepatology. 2002;36:451–5.CrossRefPubMed
21.
go back to reference Shin J, Hunt CM, Suzuki A, Papay JI, Beach KJ, Cheetham TC. Characterizing phenotypes and outcomes of drug-associated liver injury using electronic medical record data. Pharmacoepidemiol Drug Saf. 2013;22:190–8.CrossRefPubMed
Shin J, Hunt CM, Suzuki A, Papay JI, Beach KJ, Cheetham TC. Characterizing phenotypes and outcomes of drug-associated liver injury using electronic medical record data. Pharmacoepidemiol Drug Saf. 2013;22:190–8.CrossRefPubMed
22.
go back to reference Chen VL, Rockey DC, Bjornsson ES, Barnhart H, Hoofnagle JH. Incidence of idiosyncratic drug-induced liver injury caused by prescription drugs. Drug Saf. 2024;48:151–60.CrossRefPubMed
Chen VL, Rockey DC, Bjornsson ES, Barnhart H, Hoofnagle JH. Incidence of idiosyncratic drug-induced liver injury caused by prescription drugs. Drug Saf. 2024;48:151–60.CrossRefPubMed
23.
go back to reference Kwon H, Lee SH, Kim SE, Lee JH, Jee YK, Kang HR, et al. Spontaneously reported hepatic adverse drug events in Korea: multicenter study. J Korean Med Sci. 2012;27:268–73.CrossRefPubMedPubMedCentral
Kwon H, Lee SH, Kim SE, Lee JH, Jee YK, Kang HR, et al. Spontaneously reported hepatic adverse drug events in Korea: multicenter study. J Korean Med Sci. 2012;27:268–73.CrossRefPubMedPubMedCentral
24.
go back to reference Pedraza L, Laosa O, Rodríguez-Mañas L, et al. Drug induced liver injury in geriatric patients detected by a two-hospital prospective pharmacovigilance program: a comprehensive analysis using the Roussel Uclaf causality assessment method. Front Pharmacol. 2020;11: 600255.CrossRefPubMed
Pedraza L, Laosa O, Rodríguez-Mañas L, et al. Drug induced liver injury in geriatric patients detected by a two-hospital prospective pharmacovigilance program: a comprehensive analysis using the Roussel Uclaf causality assessment method. Front Pharmacol. 2020;11: 600255.CrossRefPubMed
25.
go back to reference Cabanas R, Calderon O, Ramirez E, Fiandor A, Prior N, Caballero T, et al. Piperacillin-induced DRESS: distinguishing features observed in a clinical and allergy study of 8 patients. J Investig Allergol Clin Immunol. 2014;24:425–30.PubMed
Cabanas R, Calderon O, Ramirez E, Fiandor A, Prior N, Caballero T, et al. Piperacillin-induced DRESS: distinguishing features observed in a clinical and allergy study of 8 patients. J Investig Allergol Clin Immunol. 2014;24:425–30.PubMed
26.
go back to reference Rao A, Rule JA, Hameed B, Ganger D, Fontana RJ, Lee WM. Secular trends in severe idiosyncratic drug-induced liver injury in North America: an update from the acute liver failure study group registry. Am J Gastroenterol. 2022;117:617–26.CrossRefPubMedPubMedCentral
Rao A, Rule JA, Hameed B, Ganger D, Fontana RJ, Lee WM. Secular trends in severe idiosyncratic drug-induced liver injury in North America: an update from the acute liver failure study group registry. Am J Gastroenterol. 2022;117:617–26.CrossRefPubMedPubMedCentral
27.
go back to reference Gekhman D, Correa E. One DOSE of cefazolin—months of misery: a case of acute liver failure with grave consequences: 3039. Am J Gastroenterol. 2018;113:S1664–5.CrossRef
Gekhman D, Correa E. One DOSE of cefazolin—months of misery: a case of acute liver failure with grave consequences: 3039. Am J Gastroenterol. 2018;113:S1664–5.CrossRef
28.
go back to reference deLemos AS, Ghabril M, Rockey DC, Gu J, Barnhart H, Fontana RJ, et al. Amoxicillin-clavulanate-induced liver injury. Dig Dis Sci. 2016;61:2406–16.CrossRefPubMedPubMedCentral
deLemos AS, Ghabril M, Rockey DC, Gu J, Barnhart H, Fontana RJ, et al. Amoxicillin-clavulanate-induced liver injury. Dig Dis Sci. 2016;61:2406–16.CrossRefPubMedPubMedCentral
Metadata
- Title
- The Frequency of Drug-Induced Liver Injury Due to Antibiotics Among Hospitalised Patients
- Authors
-
Robert A Björnsson
Sigurdur Sölvi Sigurdsson
Dagur Tjörvi Arnarson
Egill Logason
Einar Stefan Björnsson
- Publication date
- 12-03-2025
- Publisher
- Springer International Publishing
- Keywords
- Drug-Induced Liver Injury
Drug-Induced Liver Injury
Antibiotic
Cefazolin
Amoxicillin
Piperacillin
Ceftriaxone
Vancomycin - Published in
-
Drug Safety
Print ISSN: 0114-5916
Electronic ISSN: 1179-1942 - DOI
- https://doi.org/10.1007/s40264-025-01541-w